STOCK TITAN

CareDx to Report Second Quarter 2021 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

CareDx, Inc. (Nasdaq: CDNA) announced it will report its financial results for Q2 2021 after market close on July 29, 2021. A conference call hosted by company management will follow at 1:30 p.m. PT (4:30 p.m. ET). Investors can participate by calling 877-705-6003 domestically or 201-493-6725 internationally, using Conference ID: 13721182. Live webcasts will be available on CareDx's investor relations website.

CareDx specializes in precision medicine solutions for transplant patients, emphasizing genomics-based information throughout the pre- and post-transplant journey.

Positive
  • CareDx will report Q2 2021 financial results, which may indicate company growth.
  • The scheduled conference call suggests transparency and engagement with investors.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the second quarter 2021 after market close on Thursday, July 29, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 877-705-6003 for domestic callers or 201-493-6725 for international callers. Please reference Conference ID: 13721182. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
CareDx, Inc.
Ian Cooney
(415) 287-3550
icooney@caredx.com

 


FAQ

When will CareDx report its Q2 2021 financial results?

CareDx will report its financial results for Q2 2021 after market close on July 29, 2021.

What time is the CareDx Q2 2021 earnings call?

The CareDx Q2 2021 earnings call is scheduled for 1:30 p.m. PT (4:30 p.m. ET) on July 29, 2021.

How can I listen to the CareDx earnings call?

To listen to the CareDx earnings call, dial 877-705-6003 for domestic calls or 201-493-6725 for international calls, using Conference ID: 13721182.

What is CareDx's focus in precision medicine?

CareDx focuses on providing clinically differentiated healthcare solutions and genomics-based information for transplant patients.

CareDx, Inc.

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Stock Data

1.11B
51.79M
3.45%
96.05%
5.73%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
BRISBANE